David S. Geldmacher, MD, is Director of the Memory Disorders Program and Associate Professor of Neurology at the University of Virginia Health System in Charlottesville, Virginia. Previously, he served as Associate Professor in the Department of Neurology at Case Western Reserve University School of Medicine and Clinical Director of the Memory and Aging Center at University Hospitals of Cleveland, in Cleveland, Ohio.

Dr Geldmacher earned his MD with a certificate in academic research at the State University of New York Health Science Center at Syracuse College of Medicine. He served his internship at Mt. Sinai Medical Center and completed a residency in neurology at Case Western Reserve University School of Medicine, both in Cleveland. He completed a postdoctoral fellowship in behavioral neurology from the Center for Neuropsychological Studies at the University of Florida College of Medicine in Gainesville.

Dr Geldmacher is the recipient of numerous awards and honors. Additionally, he has been a principal investigator in several research projects on dementia and Alzheimer's disease (AD). Dr Geldmacher serves on several national educational and advisory boards, including the scientific advisory board for the Institute for the Study of Aging in New York. His committee activities include the Steering Committee for the NIA-Alzheimer's Disease Cooperative Study, and he serves as the Geriatric Neurology Section Liaison for the Medical Economics Management Subcommittee for the American Academy of Neurology. Dr Geldmacher has served as a scientific grant reviewer as well as a journal and book reviewer for a variety of journals, including Neurology, Alzheimer's Disease and Associated Disorders, the Annals of Neurology, Lancet, and the Journal of the American Medical Association. He has authored or co-authored dozens of journal articles, book chapters, and abstracts on dementia-related topics and is the author of a clinical handbook entitled Contemporary Diagnosis and Management of Alzheimer's Disease. In addition, he has lectured widely here and internationally on AD and dementia. Dr Geldmacher's professional and medical society memberships include the American Academy of Neurology, American Society of Neurorehabilitation, and Behavioral and Cognitive Neurology Society.

Dr Geldmacher disclosed the following relationships:

• Grants/Research Support: Eisai Inc., Janssen Pharmaceutica, Pfizer Inc

• Consultant: Eisai Inc., Janssen Pharmaceutica, Pfizer Inc

• Speakers' Bureau: Eisai Inc., Janssen Pharmaceutica, Pfizer Inc